Abstract

Objective: Amyotrophic lateral sclerosis (ALS) disease state prediction usually assumes linear progression and uses a classifier evaluated by its accuracy. Since disease progression is not linear, and the accuracy measurement cannot tell large from small prediction errors, we dispense with the linearity assumption and apply ordinal classification that accounts for error severity. In addition, we identify the most influential variables in predicting and explaining the disease. Furthermore, in contrast to conventional modeling of the patient’s total functionality, we also model separate patient functionalities (e.g., in walking or speaking). Methods: Using data from 3772 patients from the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) database, we introduce and train ordinal classifiers to predict patients’ disease state in their last clinic visit, while accounting differently for different error severities. We use feature-selection methods and the classifiers themselves to determine the most influential variables in predicting the disease from demographic, clinical, and laboratory data collected in either the first, last, or both clinic visits, and the Bayesian network classifier to identify interrelations among these variables and their relations with the disease state. We apply these methods to model each of the patient functionalities. Results: We show the error distribution in ALS state prediction and demonstrate that ordinal classifiers outperform classifiers that do not account for error severity. We identify clinical and lab test variables influential to prediction of different ALS functionalities and their interrelations, and specific value combinations of these variables that occur more frequently in patients with severe deterioration than in patients with mild deterioration and vice versa. Conclusions: Ordinal classification of ALS state is superior to conventional classification. Identification of influential ALS variables and their interrelations help explain disease mechanism. Modeling of patient functionalities separately allows relation of variables and their connections to different aspects of the disease as may be expressed in different body segments.

Highlights

  • Despite medical and clinical progress since its discovery 150 years ago, the inner workings and mechanisms of amyotrophic lateral sclerosis (ALS) remain largely unknown [1,2,3]

  • Since the classification task has five classes, random selection would likely yield approximately 20% classification accuracy, yet the decision tree (DT) yield between 71% and 84.7%, depending on the task setting and ALS functional rating scale (ALSFRS) item

  • For each of the ALSFRS items, we can see that the classification accuracy is improved when adding information from the first clinic visit and reduced when attempting to predict future disease state

Read more

Summary

Introduction

Despite medical and clinical progress since its discovery 150 years ago, the inner workings and mechanisms of amyotrophic lateral sclerosis (ALS) remain largely unknown [1,2,3]. It is clear today that a reliable individualized prediction of a patient’s disease progression rate could improve the ability to assess treatment influence in a clinical trial and reduce the number of patients necessary to achieve statistically significant results. ALS is a devastating illness with an unknown pathogenesis It is an idiopathic fatal neurodegenerative disease of the human motor system [4,5,21]. Despite medical and clinical progress in recent decades, the disease is still not visibly affected by the different therapies available today [1,3,6]. Clinical features include loss of neurons at all levels of the motor system: from the cortex to the anterior horn of the spinal cord and motor nuclei in the brainstem [1,5]. The recently developed Braak neuropathological staging system has shown that ALS disseminates in a sequential regional pattern from the precentral motor cortex, brainstem motor nuclei, and spinal cord motor neurons to prefrontal areas, postcentral cortex and basal ganglia, and lastly to the temporal cortex, including the hippocampus

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call